A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score.

Authors:
Zhao Z; Gu S; Yang Y; Wu W; Du L and 2 more

Journal:
BMC Cancer

Publication Year: 2024

DOI:
10.1186/s12885-023-11800-7

PMCID:
PMC10787978

PMID:
38218803

Journal Information

Full Title: BMC Cancer

Abbreviation: BMC Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe study was conducted according to the report guidelines of CHEERS and approved by the Ethics Committee of the Taizhou cancer hospital (code: IRB-[2020]NO.6). Written informed consent was obtained from study participants before their enrollment into the study. Consent for publicationNot applicable. Competing interestsAll authors declare that they have no competing interests. Competing interests All authors declare that they have no competing interests."

Evidence found in paper:

"Funding This work was supported by the Scientific Research Foundation of Nanjing University of Chinese Medicine (Grant No.013038029001)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025